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A B S T R A C T
Objective: The aim of this systematic review was to investigate the potential effect of pictograms on
patient adherence to medication therapies.
Method: PubMed, MEDLINE, Embase, CINAHL, and CENTRAL were searched for relevant articles.
Experimental studies testing the use of pictograms in patient counselling regarding medication therapy,
which quantitatively measured adherence, were included.
Results: Seventeen studies were identified that fulfilled our inclusion criteria. These were heterogeneous
with respect to study setting, population size, and the medication regimen tested. All the studies had
methodological quality limitations. The pictogram interventions differed with respect to complexity,
intervention length, and the measured adherence outcome. Ten studies (58.8 %) reported a statistically
significant effect, of the pictogram intervention in question, on patient adherence to medication
therapies. Of these, 80 % involved populations at elevated risk for non-adherence.
Conclusion and practice implications: Pictograms used in combination with written and/or oral
information can have a positive impact on patient populations that are highly at risk for non-adherence
when counselled on the proper use of medicines.
© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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journal homepage: www.else vie r .com/ locate /pateducou1. Introduction
Patient adherence to medication therapies is a primary
determinant of treatment success, and medication non-adherence* Corresponding author at: Faculty of Nursing and Health Sciences, Nord
University, PB 324, N-7501, Stjordal, Norway.
E-mail address: Hege.sletvold@nord.no (H. Sletvold).
https://doi.org/10.1016/j.pec.2019.12.018
0738-3991/© 2020 The Authors. Published by Elsevier B.V. This is an open access articis a common and recognized problem in health care [1–3].
Adherence is defined as “the extent to which a person’s
behaviour—taking medication, following a diet, and/or executing
lifestyle changes—corresponds with agreed-upon recommenda-
tions from a healthcare provider” [1]. However, many patients do
not follow treatment recommendations for different (and com-
plex) reasons [1,2]. The World Health Organization (WHO) has
defined five “dimensions” that affect adherence: The patient, the
therapy, the health system, the condition, and the socioeconomicle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
1096 H. Sletvold et al. / Patient Education and Counseling 103 (2020) 1095–1103environment [1]. Medication non-adherence may result in adverse
health outcomes and increased healthcare spending [1,3].
Medical information supports medication adherence through
facilitating the correct use of medicines and improving the level of
understanding while simultaneously generating positive attitudes
towards treatment [1]. Traditionally, information for patients
regarding correct medicine use (in Europe) involves verbal
counselling by healthcare personnel (HCP), which is supplemented
by written information in the form of a patient information leaflet
(PIL) provided by the medicine manufacturer [4]. However, several
shortcomings apply to this approach: The PILs have no consent
standards, are known for small print and lengthy texts written at
an advanced reading level, and contain generalised rather than
personalised information [5–7].
Notably, pictures or pictograms that graphically illustrate and/
or emphasise instructions for the correct use and storage of
medicines can facilitate communication between HCPs and
patients. A pictogram can be defined as a picture or symbol that
represents a word or phrase. A literature review reported that
including pictograms in patient counselling could reduce the
frequency of medication dosing errors related to the administra-
tion of liquid medications [8]. Moreover, pictograms in combina-
tion with spoken and/or written medicinal instructions have been
demonstrated to enhance the visual attention, comprehension,
and recall of medication instructions provided [8–10]. It has also
been reported that patients prefer to have pictograms and written
or oral information used in combination. This is especially true for
patients with low health literacy, as well as elderly patients [10].
Patient-centric development, as well as testing and validation in
distinct patient populations, is of importance to the utility of
pictograms used in medication counselling [11–13], hereby called
pharmaceutical pictograms.
Previous reviews have emphasised the role of pharmaceutical
pictograms on patient comprehension and recall of medication
instructions, but these include only a small number of studies that
report an effect on patient adherence [8–10]. The aim of thisFig. 1. Study flosystematic review was to investigate the potential effect of
pictograms on patient adherence to medication therapies.
Additional objectives of the study were to detect and describe
pictogram interventions that positively affect adherence and to
evaluate the potential contribution of pictograms to the efficacy of
complex interventions.
2. Methods
This is a systematic literature review performed according to
the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) Statement [14], where the databases PubMed,
MEDLINE, Embase, CINAHL, and the Cochrane Central Register of
Controlled Trials (CENTRAL) were searched for relevant studies.
An initial search in PubMed was conducted in December 2017
with the following search strategy: (pictogram OR pictograph OR
picture OR pictorial OR graphics OR visuals OR icon OR symbol)
AND (adherence OR compliance OR concordance), limited to
publication dates from 1997/01/01 to 2017/12/31, and English as
the publication language. PubMed, MEDLINE, Embase, CINAHL,
and CENTRAL were searched in May 2018 using the following
search strategy (referred to as the second search strategy):
(pictogram OR pictograph OR pictorial OR picture), combined
with (AND) the following MeSH Terms: (medication adherence
OR patient adherence OR patient compliance). These searches
were limited to English language studies published between
1997/01/01 to 2018/05/31. Additional filters were “peer reviewed”
or “academic” journals for the MEDLINE and CINAHL searches,
respectively.
The Population, Intervention, Comparison, and Outcome (PICO)
of the study were: patients on medication (Population), pictogram
(s) had to be involved in an experimental study design (Interven-
tion), no specific criteria for the comparison (C), and the studies
had to quantitatively measure adherence (Outcome). To be
included, the studies also had to report on original data and be
published in a peer-reviewed journal.w diagram.
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Usual care Self-reported adherence
by interview at baseline
and 3–5 days after
medicine dispensing,
reported as non-
adherence in % (>20 %
deviation of the
prescribed dose)
Significantly (p < 0.05)
higher adherence in the
intervention group (9.3
% non-adherent)





















Usual care Patient compliance
questionnaire 8 weeks
after surgery discharge
Significantly (p < 0.001)
higher compliance in the
intervention group (88.2
%) compared to the
control group (66.4 %)
a RCT, randomised controlled trial.
b ARVT, antiretroviral therapy; HIV, human immunodeficiency virus.
c I1, intervention in study arm one; I2, intervention in study arm two; I3, intervention in study arm three; PIL, patient information leaflet.
d MMAS-8, 8-item Morisky Medication Adherence Scale; CMG, cumulative medication gap; ARMS, Adherence to Refills and Medications Scale; MPR, medication possession
ratio; MEMS, Medication Event Monitoring System.
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Results from the initial PubMed search were evaluated separately
by the three review authors according to the inclusion criteria.
First, the results were screened by reading the article titles andexcluding articles that were not relevant according to the inclusion
criteria. Next, the study abstracts were evaluated, and non-relevant
articles were excluded. Finally, the full-text articles selected by all
three authors were collected and assessed for their relevance
H. Sletvold et al. / Patient Education and Counseling 103 (2020) 1095–1103 1099relative to the inclusion criteria. Any disagreements regarding the
eligibility of studies were reconciled at the final step by discussion
and consensus.
Results from the second search strategy in PubMed, Embase,
CINAHL, MEDLINE, and CENTRAL were initially evaluated by one of
the review authors (H.S.) by removing article duplicates and
evaluating titles and abstracts as described above. Additionally, the
reference lists of the identified studies were hand searched to
retrieve additional relevant articles. Finally, the retrieved full-text
articles were independently reviewed by two of the three authors
according to the inclusion criteria. In cases of uncertain eligibility,
all three authors read the article, and consensus on whether or not
to include the article was reached by discussion. In total, the
reviewers discussed inclusion for nine studies. Study design and
the outcome measurement (adherence measure) were reasons for
discussion for five and four studies, respectively. A study flow
diagram is provided in Fig. 1.
The included studies were independently analysed by two of
the authors, and data were extracted to present the key features of
the intervention studies and reflect on points of difference that
could affect the interpretation of the pictogram intervention. The
following variables were extracted: study setting, study design
(defined as randomised controlled trial [RCT] or non-randomised
study [NRS]), number of study participants, short description of
study participants, type of intervention(s) with emphasis on the
pictogram contribution, adherence effect measure(s), time of
adherence measurement, and adherence outcome.
The RCT studies were assessed by two of the authors for risk of
bias using the Cochrane Collaboration’s tool for assessing risk of
bias in randomised trials [15]. RCTs with a high risk of bias in four
or more dimensions were excluded. The NRSs were assessed by
two of the authors, who described pre- and post-intervention risk
of bias according to an abridged version of ROBINS-I—a tool for
assessing the risk of bias in non-randomised studies of inter-
ventions [16]. NRSs with a critical or serious risk of bias both at pre-
and post-intervention were excluded.
The heterogeneity of the studies with respect to patients,
pictogram interventions, and adherence outcome measurements
precluded a meta-analysis. Consequently, the results of this review
are presented narratively.
3. Results
Our database searches identified 1,283 studies, of which358 were
duplicate results. A total of 896 studies were excluded based on their
title or abstract, while a further twelve studies were excluded upon
full-text review. Seventeen studies were included for analysis in this
literature review, ten of which were published in the past 10 years.
The studies were initially categorised as either RCT (n = 18) or NRS
(n = 5), with pictograms being part of an intervention to increase
medication adherence or compliance. The NRSs tested pictograms
in a pre-post intervention study design, but were all excluded from
the final analysis due to poor study quality. One other study, which
was reportedly a case-control study, was included [18] since it
tested an intervention with the aim of increasing medication
adherence,and was therefore judgedbythe authors of this review to
be an RCT with an experimental study design.
The included studies were heterogeneous regarding study
setting, the number of participants, study population, the choice of
interventions and controls, and the adherence effect measurement
used (see Table 1). Regarding geographic location, six studies were
conducted in the USA, while two were conducted in India, and
three in the Republic of South Africa. The remaining six studies
were performed in Cameroon, Malaysia, Australia, Kurdistan,
Nigeria, and Malta, respectively. Studies were conducted both in
primary and secondary healthcare settings. The number ofparticipants in each study (n = number of participants at the start
of the intervention) varied between 46 [39] and 632 [26], with the
median number of participants being 135 [30]. A total of 3,995
patients were included across all studies combined. The study
population was diverse in terms of age, clinical disorders,
treatment regimens, and the level of health literacy. The most
frequently targeted medication therapies were antiretroviral
therapy (five studies) and cardiovascular medications alone or
in combination with antidiabetic medicines (four studies). The
remaining studies targeted antidiabetic medicines (two studies),
antibacterial medicines (two studies), anti-asthmatic medicines
(one study), chloroquine syrup (one study), cataract medication
(one study), and general liquid medications (one study). While
pictograms were involved in interventions regarding medication
therapy in all included studies, there were substantive differences
between the studies regarding the intervention complexity,
healthcare personnel involved in the interventions, intervention
length, and the adherence outcomes measured. As a result, there
was insufficient common ground for quantifying total differences
between intervention and control groups or estimating pooled
effect sizes for analysis across studies regarding the overall effect
on adherence.
Of the included studies,10 studies (58.8 %) reported a statistically
significant effect of pictogram interventions on patient adherence to
medication therapies. All studies were performed in hospital, clinic,
or outpatient settings. The studies differed with respect to the
medication therapies selected, number of medications, as well as
whether the treatment was short-term or for chronic use. In some
cases, sufficient details regarding the medication therapies were not
provided. For example, the study by Mansoor and Dowse involved
medicines used in antiretroviral therapy (ARVT) but did not specify
which medicines were administered [23]. In contrast, the medica-
tion therapies used in studies by Dowse and Ehlers, Ngoh and
Shepherd, and Okonkwo et al. were well defined (amoxicillin,
phenoxymethylpenicillin, and co-trimoxazole; ampicillin, sulfa-
methoxazole-trimethoprim, metronidazole, and tetracycline; chlo-
roquine syrup, respectively) [24–26]. Some studies described
polypharmacy in their study population (e.g., Murray et al., and
Zerafa et al. [18,27]), whereas others did not provide any
information regarding other medicines used [28].
In six of the ten studies demonstrating a significant effect of a
pictogram-based intervention, the interventions were complex and
involved both pictograms and medication counselling combined
with adherence tools or teach-back [18,25,27–30]. In other studies,
plain interventions using pictograms in patient medication infor-
mation and instruction leaflets [23,26], or on labels [24], also proved
to be effective in increasing patient adherence.
Various methods were used to measure adherence, including
pill count, volumetric measurements, electronic pharmacy refill
records, viral load, self-reported adherence scales, self-reported
adherence by vignettes or interviews, and the use of medication
event monitoring systems (MEMS). Consequently, the adherence
definitions and outcome effects were not reported in a consistent
manner. For instance, in a study by Dowse and Ehlers, adherence
was determined by pill count or volumetric measurement of
antibacterial tablets or suspensions, respectively. Additionally,
patients in this study reported on adherence using a questionnaire,
with a total adherence score being calculated and converted into a
percentage [24]. In contrast, Ngoh and Shepherd measured
adherence using pill counts only, and results were given as a pill
count adherence ratio [25]. Subjective self-reported adherence
effect measures were used in 11 of the studies included in this
review [18,23,24,26–28,30,34–36,38]. An example is the study by
Negarandeh et al., which utilised the “8-item Morisky Medication
Adherence Scale” (MARS-8) [30]. This study reported significant
effect on adherence using medication educational interventions
Fig. 2. Risk of bias analysis of the included RCTs. +, low risk of bias; ?, unclear risk of bias; -, high risk of bias.
Fig. 3. Cumulative risk of bias observed in the included RCTs.
1100 H. Sletvold et al. / Patient Education and Counseling 103 (2020) 1095–1103consisting of pictograms [30]. Such a questionnaire defines
adherence according to the specific scale used, rather than an
adherence percentage. Zerafa et al. used a novel self-made
questionnaire named “Assessing Patient Compliance” that
reported each patient’s mean percentage compliance as calculated
by the total number of correct and incorrect answers [18]. The
study found a significant effect on patient compliance upon
comparing a pharmacist intervention of medication counselling
and written medication information sheets (including pictograms)
to standard care [18]. Mixed methods were used in six of the
studies [23,24,26,27,29,32], of which five studies reported a
significant pictogram intervention effect [23,24,26,27,29]. When
using mixed methods, adherence outcomes were either reported
separately ([23,29] or in combination [24,26,27].
Among the ten studies reporting significant effects of picto-
gram-based interventions, heterogeneity was observed in the
choice of patient group. Examples of patient groups include HIV
patients on antiretroviral therapy (ARVT), patients on antibacterial
medications, cardiac and diabetic patients, and children on
medication (see Table 1). Patient groups known to experience
challenges with adherence, such as patient populations with low
(health) literacy [23–25,29,30,33] and children and/or their
caregivers [26,28], were involved in eight of the ten studies (80 %).
All included RCTs were assessed according to the Cochrane
Collaboration’s tool for assessing risk of bias in randomised trials
[15]. This involved a thorough analysis of the risk of bias across
seven dimensions: 1) Random sequence generation (selection
bias); 2) Allocation concealment (selection bias); 3) Blinding of
participants and personnel (performance bias); 4) Blinding of
outcome assessment (detection bias); 5) Incomplete outcome data
(attrition bias); 6) Selective reporting (reporting bias); and 7)
Other bias. The individual results of this analysis are provided in
Fig. 2. Fig. 3 presents the cumulated results as stacked bars,
presenting the relative frequencies of studies deemed to have a
low, unknown, or high risk of bias in each of the seven dimensions.
Our results demonstrate that, without exception, all of the RCTs
identified and included in this review had a high risk of bias in at
least one dimension. Notably, they all had a high risk of
performance bias, reflecting insufficient blinding of participants
and/or personnel. In three of the studies [27,29,36], researchers
were blinded to compensate for difficulties in the blinding of
participants and care providers to the use of pictogram-based
interventions. However, while we consider this an improvement
over no blinding at all, the fact that participant allocation is known
to the participants themselves, as well as the care providers, must
be considered to result in a high risk of performance bias.
The second greatest contributor to study bias in this review was
the insufficient blinding of outcome assessments, leading to a high
risk of detection bias in 10 of 17 studies. Considerable risk of bias
was also identified in the dimensions of selective reporting(4 studies with high risk of bias) and allocation concealment
(3 studies with high risk of bias). A high risk of attrition bias was
only observed in one study [22]. The majority of studies had a low
risk of bias regarding random sequence generation, while six
studies had an uncertain level of risk in this dimension.
Five studies were excluded from the review following a full-text
reading, since they did not quantitatively measure adherence
[40–44], while one study was only a study protocol [45].
Additionally, six studies were excluded because of poor study
quality. One RCT study was excluded due to high risk of bias in four
or more dimensions [22]. Five of the excluded studies were non-
randomised studies [17,19–21,31]. A critical risk of pre-
intervention bias was observed in all five studies. In the study
by Gazmararian et al., the intervention and control groups were
located at different study sites [31]. Moreover, studies by Hawkins
et al. and Martin et al. used convenience sampling of study
participants [20,21], while the study by Vetter et al. used time-
sequential sampling [17]. Notably, the study by Rodrigues et al.
lacked information to judge the risk of bias in study participant
selection [19]. All five studies were observed to have a critical or
serious risk of post-intervention bias as well as bias in the
measurement of outcomes [17,19–21,31], while Gazmararian et al.
and Rodrigues et al. also had bias in the selection of reported results
[19,31]. Two of the studies were pilot studies with a small number
of participants [20,21].
4. Discussion and conclusion
4.1. Discussion
In this review, we have assessed studies designed to evaluate
the effect of pictogram-based interventions on patient adherence
H. Sletvold et al. / Patient Education and Counseling 103 (2020) 1095–1103 1101to medications. From a sizeable and diverse evidence base, various
uses of pictograms and different measures of adherence were
investigated. Heterogeneity in the design and conduct of the
included studies precluded any meta-analysis of observed
pictogram effects. However, of the 17 studies included, 10 studies
(58.8 %) reported a statistically significant effect of pictogram-
containing interventions on patient adherence to medication
therapies.
The pictograms utilised in the studies varied, though the
majority of study interventions utilised pictograms in combination
with verbal medication counselling or text-based instructions of
medication therapy. A review by Katz et al. concluded that
pictograms used to complement textual or oral information were
more effective at improving patients’ understanding of correct use
of medicines than pictograms alone [10]. The current review points
to a possible effect of pictograms in combination with oral or text-
based medication information or counselling when it comes to
improving patient adherence.
The absence of significant effects on patient adherence was
common among many of the reviewed studies. We primarily
attribute this to insufficient sample sizes. Measuring adherence
has proven difficult in many cases, and there is a need for
standardisation of reproducible adherence measures. Among the
studies included in this review, self-reported adherence by
questionnaire or interview was the most consistently successful
measure for identifying differences in adherence. However, other
methodological aspects may have also contributed to the lack of
significant results in many of the studies. Notably, we have found
sufficient evidence in our review to sustain the assumption that
pictogram-based interventions may indeed serve to improve
patients’ adherence to medication therapies (see Table 1).
The complexity of interventions limits our ability to interpret
the exact contribution of the pictograms on medication adherence.
For instance, the study by Kalichman et al. utilised pictograms in
combination with adherence counselling and adherence tools to
enhance antiretroviral therapy [29]. While the study reported
statistically significant effect on adherence, it could not determine
the exact contribution of pictograms on the observed outcome. In
the RCT study by Negarandeh et al., an intervention consisting of
diabetes medication education by a nurse combined with teach-
back or pictograms (in two separate intervention groups), was
tested against standard care [30]. Significant differences in
medication adherence were observed between the intervention
groups and the control group, though no significant differences
were observed between the two intervention groups [30]. In
contrast, the RCT by Mansoor et al. tested PILs with or without
pictograms in two different intervention groups compared to
standard care. In this case, adherence to ARVT improved
significantly when patients received PILs with pictograms when
compared to the other two groups [23]. To test the true effect of
pictograms, study designs must allow for comparison of two
interventions where the use of pictograms constitutes the only
difference.
Patient-related factors may contribute to medication adher-
ence, since age, literacy, and cognitive function have all been
identified as negatively impacting adherence [1,2]. In eight of the
ten studies with significant intervention effects, patient popula-
tions constituted individuals with low health literacy or low age.
Dowse and Ehlers tested medicine labels incorporating pictograms
on Xhosa African patients using antibacterial medications and
observed an effect of literacy on adherence when results were
pooled for intervention and control groups [24]. Furthermore, the
study by Kalichman et al. described an adherence counselling
intervention including pictograms, in which an effect was found
among the marginal literacy HIV patients on ARTV, but with
conflicting results among lower literacy patients [29]. In thestudies by Mansoor et al., Negarandeh et al., and Ngoh and
Shepherd, the role of literacy in affecting medication adherence
was not tested, yet the study populations were selected with
literacy as one of the selection criteria [23,25,30]. These results
indicate that pharmaceutical pictograms are particularly beneficial
to patient populations challenged by low levels of health literacy.
Another factor known to influence adherence is the nature of
the therapy [1,10]. The studies in this review were highly diverse
regarding therapy type and were described with varying levels of
detail. For instance, in the RCT by Negarandeh et al., adherence
among type 2 diabetic patients was measured, though no details
were provided regarding the prescribed therapies of the study
participants [30]. Similarly, a number of the reviewed studies
failed to describe the participants’ medication therapies in
sufficient detail [18,23,28,29]. However, all of these studies
described a significant effect of pictogram-based interventions
on medication adherence. Therapeutic aspects known to affect
adherence include frequency of dosing, complexity of treatment,
adverse effects of treatment, the patient's beliefs and attitudes
regarding the treatment, and medication effectiveness [1,2]. It is
not known to what extent these factors have influenced the results
of the studies included in this review.
Several different measures of adherence were observed in the
reviewed studies. A gold standard adherence measure should be
user friendly, highly reliable, flexible, practical, cheap, and easy to
perform. Unfortunately, no single method exists, and a mixed
method approach is therefore recommended [46]. In this review,
six out of 17 studies used a mixed method approach to measure
adherence [23,24,26,27,29,32], and five of these studies reported a
significant adherence effect [23,24,26,27,29]. Evidently, when
using several methods of measurement for the same outcome
effect, the analysis and interpretation of results becomes more
complex. Therefore, it is important to choose complementary
rather than potentially conflicting measures; for example, a
combination of a subjective and an objective measurement, with
suitability for the study setting, study participants, and any other
practical considerations. Many studies in this review (n = 11)
utilised subjective self-reported adherence effect measures (e.g.,
questionnaires) to assess pictogram effect. We recommend using
consistent and validated questionnaires, in the interest of enabling
statistical comparisons across studies. Self-reported adherence
scales can measure medication-taking behaviour, and can also
identify adherence barriers and/or patient beliefs associated with
adherence [47]. When measuring adherence in any intervention
study, selecting the most suitable questionnaire remains
important.
The studies included in this review were generally of poor
quality. One challenge with pictogram-based interventions is that
study participants, in general, cannot be blinded. Still, only three
studies described researchers being blinded to participant alloca-
tion [27,29,36], while only six studies reported using measures to
blind the outcome assessment [29,32,33,36–38]. Furthermore, five
studies did not describe the method used to create a random
allocation sequence [23–25,33,36], and seven studies had a high
risk of selection bias due to insufficient allocation concealment
[18,23–25,33–35]. Unfortunately, the observed challenges with
study quality complicated our assessment of the reported results
and prohibited statistically sound cross-study comparisons.
While some previous reviews have investigated the effect of
pictograms on patient adherence to medications, they covered a
very limited evidence base. The review by Katz et al. concluded that
pictograms enhance patients’ understanding of medication-taking
behaviour, yet included only two studies that assessed adherence
[10]. Furthermore, Chan et al. reviewed the effects of pictograms
when assisting caregivers in liquid medication administration and
suggested that pictograms might reduce dosing errors, enhance
1102 H. Sletvold et al. / Patient Education and Counseling 103 (2020) 1095–1103the comprehension and recall of medication instructions, and
improve adherence [8]. However, this review included only five
studies, and only one study that measured adherence as an
outcome [8]. Barros et al. aimed to evaluate the use of pictograms
in a healthcare setting to assess their potential effect on patient
understanding and medical instruction compliance [9]. They
concluded that pictograms can serve as communication tools to
enhance visual attention, comprehension, recall, and adherence of
provided instructions, though they did not analyse the effects on
adherence in detail [9]. Additionally, the review by Nicolson et al.
concluded that there is some evidence that written information
can improve patients’ knowledge regarding medicines when
compared to no written information; however, due to the poor
quality of included studies, the review lacked robust conclusions
[48]. Finally, a review of reviews by Ryan et al., that assessed the
effects of interventions that targeted healthcare consumers to
ensure safe and effective use of medicines, found limitations in the
methodological quality of included studies, both at the review and
study level [49].
4.2. Implications
The present review documents a possible effect of pictograms on
patients’ adherence to medications, especially when combined with
written and/or oral medication information and utilised on patient
populations at high risk of non-adherence. However, the heteroge-
neity in study design and quality, as well as in the interventions and
outcomes measured, prevented us from conclusively asserting that
pictograms are effective in improving adherence.
We find it critical that studies examining the effects of
pictograms have a high-quality study design adhering to best
practises of intervention studies, and use consistent and validated
outcome measures of adherence. As such, there remains a need for
more high-quality studies, as well as a set of standardised tools and
protocols—ideally open source—that are tailored to adherence
studies. Moreover, studies assessing the value of pharmaceutical
pictograms would benefit from establishing best practices in the
design and use of the pictograms themselves.
4.3. Limitations
The present review includes studies from 1997 until 2018;
hence, studies up to 20 years old were included [25,36]. Studies
performed before the Consolidated Standards of Reporting Trials
(CONSORT) statement of 2010 [50], which defines best practice in
reporting RCTs, may be of poorer quality. Recent developments in
the healthcare sector, and in the ways patients receive and access
information, may also have rendered the older studies less
relevant. Among the studies included in this review, ten of 17
studies were conducted in 2010 or later. The level of patient
adherence majorly impacts health and healthcare expenditure and,
hence, adherence served as a natural outcome measure for this
review. For the patients themselves, however, the consequences of
non-adherence may be difficult to grasp. From the perspective of
healthcare personnel, using pharmaceutical pictograms may serve
to improve the quality of the information provided to patients, yet
evaluating the impact of pictograms on patient adherence may still
prove difficult due to their indirect relationship. Other study
endpoints could reveal a more direct relationship between the use
of pictograms and clinical outcome, though for the time being, we
consider adherence to be the gold standard.
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